CoChat

Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD

Burt, Morton G., Roberts, Gregory W., Aguilar-Loza, Norma R., Frith, Peter, Stranks, Stephen N. · 2011 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

CONTEXT: Endogenous glucocorticoid excess (Cushing's syndrome) predominantly increases postprandial glucose concentration. The pattern of hyperglycemia induced by prednisolone has not been well characterized. OBJECTIVE: Our objective was to define the circadian effect of prednisolone on glucose concentration to optimize management of prednisolone-induced hyperglycemia. DESIGN AND SETTING: This was a cross-sectional study in a teaching hospital. PARTICIPANTS: Participants included 60 consecutive consenting subjects with chronic obstructive pulmonary disease admitted to hospital: 13 without known diabetes admitted for other indications and not treated with glucocorticoids (group 1), 40 without known diabetes admitted with an exacerbation of chronic obstructive pulmonary disease and treated with prednisolone (group 2, prednisolone = 30 ± 6 mg/d), and seven with known diabetes treated with prednisolone (group 3, prednisolone = 26 ± 9 mg/d). MAIN OUTCOME MEASURE: Interstitial glucose concentration was assessed during continuous glucose monitoring. RESULTS: Significantly more subjects in group 2 [21 of 40 (53%), P = 0.02] and group 3 [seven of seven (100%), P = 0.003] recorded a glucose of at least 200 mg/dl (≥11.1 mmol/liter) during continuous glucose monitoring than in group 1 [one of 13 (8%)]. The mean glucose concentration between 2400-1200 h for group 3 (142 ± 36 mg/dl) was significantly greater than in the other two groups (P < 0.005), whereas mean glucose concentrations between 2400-1200 h in group 1 (108 ± 16 mg/dl) and group 2 (112 ± 22 mg/dl) were not significantly different. In contrast, the mean glucose concentrations between 1200-2400 h for group 2 (142 ± 25 mg/dl) and group 3 (189 ± 32 mg/dl) were both significantly greater than group 1 (117 ± 14 mg/dl, P < 0.05 for both comparisons). CONCLUSIONS: Prednisolone predominantly causes hyperglycemia in the afternoon and evening. Treatment of prednisolone-induced hyperglycemia should be targeted at this time period.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2010-2729

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 22 references

Cited by

See all 203

Metadata

Authors
Burt, M. G., Roberts, G. W., Aguilar-Loza, N. R., Frith, P., & Stranks, S. N.
Affiliations
  • Flinders University (AU)
  • Repatriation General Hospital (AU)
Corresponding author
Burt, Morton G.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-06
Volume
96
Issue
6
Pages
1789-1796
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2042010542
Cited by
203
References
22
Citations by year
2026: 8 · 2025: 11 · 2024: 10 · 2023: 14 · 2022: 12 · 2021: 16 · 2020: 25 · 2019: 14 · 2018: 17 · 2017: 10 · 2016: 13 · 2015: 9 · 2014: 13 · 2013: 18 · 2012: 8
FWCI
11.53
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
prednisolone, glucocorticoid-induced hyperglycemia, Cushing's syndrome, chronic obstructive pulmonary disease, COPD exacerbations, continuous glucose monitoring, interstitial glucose, postprandial hyperglycemia, diabetes mellitus, glucocorticoid adverse effects, timing of corticosteroid administration
MeSH terms
Aged, Aged, 80 and over, Anti-Inflammatory Agents, Blood Glucose, Cross-Sectional Studies, Female, Glycated Hemoglobin, Humans, Hyperglycemia, Male, Middle Aged, Prednisolone, Prospective Studies, Blood Glucose Self-Monitoring, Patient Selection, Postprandial Period, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD. https://app.cochat.ai/papers/10.1210/jc.2010-2729
The paper
Burt, M. G., Roberts, G. W., Aguilar-Loza, N. R., Frith, P., & Stranks, S. N. (2011). Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-2729

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.